About
Technology
Issues
FAQ
Links
Official Page
Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.